Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Why Provenge Could Be a $10 Billion Drug for Dendreon
Why Provenge Could Be a $10 Billion Drug for Dendreon
Why Provenge Could Be a $10 Billion Drug for Dendreon
Submitted by
admin
on April 11, 2011 - 11:44am
Source:
Seeking Alpha
News Tags:
Provenge
prostate cancer
Dendreon
vaccines
Headline:
Why Provenge Could Be a $10 Billion Drug for Dendreon
Do Not Allow Advertisers to Use My Personal information
